{"id":152193,"date":"2020-11-19T05:11:31","date_gmt":"2020-11-19T10:11:31","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/immutep-completes-a-a29-6-million-placement-to-accelerate-and-broaden-its-clinical-development\/"},"modified":"2024-08-18T11:40:28","modified_gmt":"2024-08-18T15:40:28","slug":"immutep-completes-a-a29-6-million-placement-to-accelerate-and-broaden-its-clinical-development","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/immutep-completes-a-a29-6-million-placement-to-accelerate-and-broaden-its-clinical-development.php","title":{"rendered":"Immutep Completes a A$29.6 Million Placement to Accelerate and Broaden its Clinical Development"},"content":{"rendered":"<p><![CDATA[?Sydney, Australia, Nov.  19, 2020  (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) : Australian biotechnology company Immutep Limited (\u201cImmutep\u201c or the \u201cCompany\u201c), which is listed on NASDAQ and the Australian Securities Exchange, is pleased to announce that it has today successfully completed a A$29.6 million a private placement of ordinary shares to professional and institutional investors (Placement).]]><\/p>\n<p>See the original post:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener noreferrer\" href=\"http:\/\/www.globenewswire.com\/news-release\/2020\/11\/18\/2129687\/0\/en\/Immutep-Completes-a-A-29-6-Million-Placement-to-Accelerate-and-Broaden-its-Clinical-Development.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"Immutep Completes a A$29.6 Million Placement to Accelerate and Broaden its Clinical Development\">Immutep Completes a A$29.6 Million Placement to Accelerate and Broaden its Clinical Development<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>See the original post: Immutep Completes a A$29.6 Million Placement to Accelerate and Broaden its Clinical Development <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/immutep-completes-a-a29-6-million-placement-to-accelerate-and-broaden-its-clinical-development.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-152193","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/152193"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=152193"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/152193\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=152193"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=152193"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=152193"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}